Sara Nochur - 03 Dec 2021 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
Director
Signature
/s/ Elisabeth Leiderman, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
06 Dec 2021, 15:19:26 UTC
Next filing
07 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 03 Dec 2021 Common Stock 20,000 $6.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on December 3, 2021 for 20,000 shares. The shares underlying the option vest in equal monthly installments until the third anniversary of the grant date, subject to the reporting person's continued service.